Anna Groner

Anna Groner has a wealth of experience in the scientific field. Anna began their career in 2005 as a Scientific Writer for Checkbiotech. In 2006, they became a PhD student at Ecole Polytechnique fédéral de Lausanne. From 2011 to 2016, they were a Postdoctoral Research Fellow at Dana-Farber Cancer Institute. In 2016, they took on the role of Ambizione Research Fellow at ETH Zürich. From 2017 to 2022, they served as Lab Head Cancer Biology at Basilea Pharmaceutica. Currently, they are a Senior Principal Scientist at Skyhawk Therapeutics.

Anna Groner's education history includes obtaining a PhD from EPFL (École polytechnique fédérale de Lausanne) in 2011, a Masters from the University of Geneva in 2006, and a Diploma from the University of Basel in 2005. Her fields of study include National Center for Competence in Research "Frontiers in Genetics", Molecular Genetics, and Molecular Biology.